The accumulation of misfolded proteins is a fundamental pathogenic process in neurodegenerative diseases. However, the factors that trigger aggregation of -Synuclein 
Accumulation of amyloid deposits is a defin ing feature of most neurodegenerative dis orders. The highly soluble presynaptic protein Synuclein (Syn; Clayton and George, 1998) is the major component of Lewy bodies (LBs) and Lewy neurites (LNs), the intracellular inclusions that are the neuropathological hall marks of dementia with LBs (DLBs), Parkinson's disease (PD), and other synucleinopathies (Spillantini et al., 1998a) . Although the pro gressive accumulation of aggregated Syn in patients parallel the decline in motor and/or cognitive function (Baba et al., 1998; Braak et al., 2003; Klucken et al., 2006) , the events triggering Syn pathology in the central nervous system (CNS), and the processes linking LBs/LNs to neurodegeneration, are poorly understood. Importantly, the pro gression of Syn pathology in PD appears to follow a stereotypical pattern that com mences in the brainstem and extends rostrally to neocortical regions (Braak et al., 2003; Fahn, 2003) . This hierarchical and predictable pattern of disease progression suggests that cell-cell transmission of Syn pathology is the basis for the spreading, most likely affect ing cells within interconnected neuronal path ways (Braak et al., 2003) . Supporting this hypothesis is the observation that embryonic mesencephalic neurons grafted into the neo striatum of PD patients develop LBs (Kordower et al., 2008; Li et al., 2008) . However, although cell-cell transfer of soluble Syn within the CNS has been reported (Desplats et al., 2009; Danzer et al., 2011; Hansen et al., 2011) , the transmission of pathological Syn species and its potential role in the pathogenesis of DLB/ PD and related synucleinopathies remain largely unexplored. sites, other severely affected areas included frontal cortex, thalamus, hypothalamus, brainstem nuclei, and major white matter tracts (e.g., callosal and commissural fibers). In contrast, lysateinjected mice examined at 30 dpi showed significantly less severe pSyn pathology that was primarily restricted to the vicinity of the injection sites ( Fig. 1 H, top) , indicating that Syn pathology amplifies and expands through the CNS in a timedependent fashion.
Host expression of soluble Syn is absolutely required for de novo formation of these PDlike inclusions because inoculation of the same symptomatic M83 mouse brain lysates into Syn-null (Syn / ) animals, which express neither mouse nor human Syn, resulted in weak Syn and pSyn immunostaining at 7 dpi only at injection sites consistent with residual inoculated material (unpublished data). Fur thermore, no Syn immunoreactivity was detected in these Syn / mice by 90 dpi, suggesting the injected Syn seeds were degraded by this time. Inoculation of M83 ani mals with brain homogenates from young asymptomatic M83 mice also failed to elicit Syn pathology for up to 164 dpi. Thus, pathological Syn in symptomatic brain lysates from M83 mice is the agent capable of initiating and propagating Syn pathology in these Tg mice.
Because insoluble Syn species occur only in symptom atic M83 brains (Giasson et al., 2002) and could be responsi ble for transmission of Syn pathology, we hypothesized that Syn amyloid fibrils alone are responsible for the initiation and propagation of this pathology. To this end, we generated PFFs in vitro from recombinant Syn proteins (Murray et al., 2003) and examined whether they exhibited pathologyseeding activity similar to brain lysates from affected M83 mice (Fig. 1, C-E) . Remarkably, injection of healthy M83 mice with PFFs assembled from human Syn 1120 Myc, a Cterminal truncated form of WT human Syn containing the Myc epitope (Luk et al., 2009) , also elicited robust LB/LNlike pSyn pathology with a neuroana tomical distribution identical to that seen in lysateinjected animals ( Fig. 2 A) . Like their lysateinjected counterparts, the Syn pathology in these PFFinjected M83 mice also spread progressively with time to distal CNS regions ( Fig. 2 A and  Fig. S1 ). Inoculation with PFFs generated from the full length WT Syn protein also led to the development of pathology that was equivalent to Syn 1120 Myc PFFs with respect to both severity and CNS distribution (Fig. 2 A) . Thus, both synthetic WT fulllength Syn and Syn 1120 Myc PFFs are sufficient to initiate and propagate Syn pathology in vivo in the same manner as brain lysates obtained from symptomatic M83 animals.
The Syn pathology in M83 mice injected with either symptomatic lysates or Syn PFFs was consistently more severe and widely distributed than that seen in noninjected Tg mice that had become symptomatic with age ( Fig. 2 A, bottom; Giasson et al., 2002) . Although the youngest age at which Syn pathology was detectable in noninjected M83 mice was 8 mo, but more typically after 12 mo of age, pro fuse Syn pathologies could be found in 100% of animals As with other neurodegenerative disease-related proteins, aggregation of Syn occurs as a nucleationdependent pro cess (Wood et al., 1999) . Polymerization of Syn into amy loid fibrils is greatly accelerated by the presence of minute quantities of aggregated or fibrillar Syn serving as nucle ation sites, indicating that the formation of intermediates or "seeds" represents an important ratelimiting step. We and others have recently demonstrated that fibrillar Syn assem bled from recombinant Syn protein is internalized by cul tured cells and neurons, where they seed the recruitment and conversion of soluble Syn into insoluble pathological LB/ LNlike inclusions (Desplats et al., 2009; Luk et al., 2009; VolpicelliDaley et al., 2011) . Using a transgenic (Tg) model of synucleinopathies (Giasson et al., 2002) , we demonstrate here that pathological Syn derived from diseased tissues and, more significantly, entirely synthetic Syn preformed fibrils (PFFs) greatly accelerate the formation and propaga tion of pathological inclusions throughout the murine CNS that are highly reminiscent of LBs/LNs. Indeed, we provide the first evidence that synthetic Syn PFFs alone can induce PDlike Syn pathology and transmit disease in vivo. Thus, both synthetic and diseaseassociated forms of Syn aggre gates initiate a cascade of pathological events in vivo that are mediated by aggregation and transmission of this protein and which culminate in a highly lethal DLBlike phenotype.
RESULTS
Tg mice expressing human Syn bearing the familial PD related A53T mutation (M83 line) develop neurological symptoms, including abnormal posture, seizures, and paraly sis, after 12 mo of age (Giasson et al., 2002) . To investigate whether diseaseassociated aggregated Syn can seed pathol ogy in vivo, we injected healthy 2-5moold M83 mice with homogenates prepared from brainstem and spinal cord of aged (>12moold) symptomatic M83 animals that contained abundant LB/LNlike Syn pathology (Fig. 1, A , B, and D). Lysates were stereotaxically injected into the neo cortex and striatum ( Fig. 1 E) , regions that are affected in PD and have extensive afferent and efferent connections with other CNS areas (Bernheimer et al., 1973; Nieuwenhuys et al., 1982; MacDonald and Halliday, 2002) .
When examined 90 d postinjection (dpi), abundant Syn lesions were detected throughout the CNS of these mice by immunohistochemistry for hyperphosphorylated Syn (pSyn; Fig. 1 F) , a marker of pathological Syn (Fujiwara et al., 2002; Waxman and Giasson, 2008) . In stark con trast, Syn pathology was completely undetectable in age matched M83 mice 90 dpi with PBS (Fig. 1, G and H, bottom), indicating that this Syn pathology did not result from the surgical procedure or reflect the Syn transgeneinduced pathology, which typically occurs at least 2 mo later. Despite the fact that inoculations were unilateral, LB/LNlike intra neuronal Syn deposits were widely distributed bilaterally and present throughout the anterior/posterior extent of the neural axis spanning the CNS from olfactory bulb to spinal cord (Fig. 1, F and H, middle) . In addition to the injection resulted in CNSwide Syn pathology (un published data).
The Syn inclusions that formed in lysate or PFF inoculated mice resembled LBs and LNs found in PD and DLB brains, as they showed strong immunoreactivity to antibodies recognizing diseasespecific conformations of Syn and ubiquitin (Fig. 2 B ; Spillantini et al., 1998b; Sampathu et al., 2003) . Abnormal Syn in both perikaryal and neuritic inclusions colocalized with ThioflavinS staining ≥30 dpi with symptomatic lysate (n = 21) or recombinant PFFs (n = 13; Fig. 1 H, Fig. 2 A, and Fig. S1 ). In contrast, pathology was undetectable in M83 mice up to 90 d after inoculation with PBS (n = 11) or brain lysate prepared from asymptomatic animals (n = 4). Thus, the pathological Syn species are highly potent in rapidly seeding aggregation of Syn in living animals. Indeed, inoculation with as little as 5 ng of pathological Syn in the form of PFFs was sufficient to induce visible pSyn accumulations in M83 mice at the level of the injection sites, whereas higher quantities of PFFs Fig. 3 A) , suggesting that recruitment and con version is specific to Syn itself. The relative levels of Syn within formic acid-soluble fractions from different CNS regions in M83 mice injected with pathological Syn also mirrored the extent of pathology detected histologically (Fig. 3 B) . Thus, the accelerated formation of Syn pathology observed in animals inoculated with a pathogenic form of the protein correlates with biochemical and posttranslational modifications of Syn that are characteristic of PD and related synucleinopathies.
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Given that PFFs generated from Syn 1120 Myc lack the Ser129 phosphoepitope recognized by antipSyn, the detec tion of LB/LNlike pSyn pathology after their injection into ( Fig. 2 C) indicating that they were comprised of amyloid fibrils formed by Syn.
Consistent with this massive burden of Syn pathology revealed by immunostaining, biochemical analysis of CNS homogenates from Syn-inoculated mice showed a marked increase in detergentinsoluble Syn compared with unin jected symptomatic M83 mice (Fig. 3, A and B) . A mixture of monomer and high molecular weight species suggestive of multimers and/or ubiquitinated Syn were recovered in SDS and formic acidsoluble fractions. In addition to human A53T Syn, endogenous murine Syn was also recruited into the insoluble aggregates, whereas the solubility of Syn, a closely related member of the synuclein family, remained Syn (Fig. 3 A; e.g., Syn211) gives further support to the notion that soluble Syn expressed by M83 animals is recruited to inclusions.
As the exogenous pathogenic Syn species likely act as a seed for recruiting endogenous Syn into intracellular inclusions, we examined whether Syn 1120 Myc PFFs were M83 mice overexpressing fulllength human Syn confirms that inclusions induced by the inoculations contain both human Syn and endogenously expressed mouse Syn (Fig. 3, A and C) . The observation by immunoblot that the bulk of detergentinsoluble Syn was detectable by anti bodies specifically recognizing the C terminus of human To further understand the relationship between transmis sion of Syn pathology and this disease phenotype, we char acterized the anatomical distribution of Syn inclusions at 30 and 90 dpi with either symptomatic lysate or Syn PFFs (Fig. 5) . At 30 dpi, inclusions were confined to the injection site and immediate surrounding areas, in agreement with the recruitment of Syn expressed by M83 mice into seeded aggregates (Fig. 5 A) . By 90 dpi, Syn pathology was far more widespread and abundant, even when compared with aged M83 mice. Moreover, lysate and PFFinjected mice displayed nearly identical spatial distributions of pSyn pathol ogy at both time points examined (Fig. 5 A) , indicating that recombinant Syn PFFs are qualitatively equivalent to lysates derived from symptomatic M83 brain tissue in their capacity to propagate Syn pathology in vivo.
These mapping studies further revealed that regions which developed the most prominent Syn pathology after injection of symptomatic lysate or Syn PFFs were those containing neurons that project to, or receive input from, the inoculation sites (e.g., frontal cortex and thala mus). A CNSwide survey of all regions exhibiting Syn inclusions in lysate and PFFinoculated M83 mice re vealed that regions sharing significant interconnections displayed the most severe pathology (Fig. S1 ), suggesting that propagation of pathological Syn occurs most readily between associated neuronal populations. Supporting this hy pothesis, accumulation of hyperphosphorylated Syn was also apparent in neurons of the substantia nigra pars com pacta, a population of neurons that provides dopaminergic innervation to the dorsal striatum and is highly susceptible to accumulation of LBs/LNs in human PD (Fig. 5 B) . Nigral neurons bearing Syn inclusions also showed visible reduc tions in tyrosinehydroxylase staining, suggesting impaired dopamine production in these cells. Finally, the Syn pathol ogy in the injected M83 mice was also accompanied by astro gliosis and microgliosis, which are indicative of progressive neurodegeneration (Fig. 5 C) . In addition, brain lysates from symptomatic M83 mice injected separately into either the neocortex or striatum induced distinct, yet complementary, distributions of Syn pathology that were consistent with internalized by neurons after stereotaxic injection. Indeed, focal pSyn immunostaining surrounding Syn 1120 Myc in ternalized by neurons in the cortex and striatum was apparent in PFFinjected M83 mice at 7 dpi (Fig. 3, D and E) . In contrast, Syn / mice showed only negligible Mycimmunostaining at PFF injection sites at 7 dpi, suggesting that the recruitment and conversion of Syn expressed by M83 animals to exog enously introduced seeds represents an early step in the forma tion of Syn inclusions (unpublished data).
The acceleration and increased accumulation of Syn pathology in M83 mice injected with either symptomatic lysate or Syn PFFs was associated with a dramatic reduc tion in survival when compared with uninjected M83 animals (median of 204 d for M83injected vs. 316 d for M83uninjected control mice), all of which eventually suc cumb to disease from the transgenedriven expression of A53T mutant Syn (Fig. 4 A) . Interestingly, the lag period between inoculation with pathological Syn and the ap pearance of motor symptoms was highly uniform (median of 100 d) irrespective of the animal's age at injection (Fig. 4 B) , correlating closely with the emergence of extensive Syn pathology (i.e., 90 dpi). In contrast, neurological deficits in uninjected M83 mice or those that were treated with either PBS or homogenates from asymptomatic animals did not emerge until the appearance of Syn inclusions resulting solely from the transgenedriven expression of mutant A53T Syn, which occurred variably between 226-462 d of age, with none succumbing to disease before 175 dpi (Fig. 4 A; Giasson et al., 2002) . Thus, the amplification and transmission of pathological Syn in the M83 mice in jected with pathological Syn is directly associated with a rapid and predictable disease process linked to the onset of motoric symptoms. The similarity in phenotype be tween Syn-inoculated M83 mice and those that devel oped symptoms through advanced aging (e.g., paralysis beginning in the hindlimbs) corresponded to the massive brainstem and spinal cord Syn pathology observed and is consistent with CNS damage previously reported in older Tg mice expressing A53T Syn (Giasson et al., 2002; Martin et al., 2006) . Although we cannot rule out the possibility that small quantities of pathological Syn from the inoculum itself or from affected cells infiltrated the ventricular space, the distinct segregation between the distributions of pathology resulting from separate injections into neocortex versus striatum, along with the lack of any periventricular pathol ogy, suggests that dissemination through the cerebrospinal fluid plays a minor role in transmission of pathological Syn. Moreover, several areas adjacent to heavily affected regions, most notably the hippocampus, showed only limited their known afferent and efferent pathways (Fig. 6 A) . When superimposed, these two patterns recapitulated the full extent of pathology seen in M83 mice that were injected at both sites (Fig. 5 A) , indicating that the neuronal connectiv ity of the initial seeding site is a major determinant of the route of Syn propagation. Interestingly, a subset of astro cytes that express Syn in this Tg line contained robust pSyn pathology, suggesting that nonneuronal cells are also capable of internalizing pathological Syn and forming seeded Syn inclusions (Fig. 5 D) . inclusions in spinal cord neurons and deep cerebellar nu clei is further concordant with this hypothesis, although it remains to be established whether this occurred through transmission of pathological Syn through secondary or tertiary synaptic circuits such as pontine or medullary con nections (Fig. 6, B and C) .
Immunoreactive Syn inclusions were detected in axons of the corpus callosum, anterior commissure, and corticospinal Syn pathology, suggesting that pathological Syn does not spread indiscriminately. Rather, consistent with the hypothesis that pathological Syn may be directly trans mitted between neuronal populations, antipSyn immuno histochemistry in sagittal sections from lysateinjected mice showed that Syn pathology was concentrated along major telencephalic axonal pathways (e.g., lateral and medial forebrain bundles; Fig. 6, B-E) . The detection of Syn demonstrating the cell-cell transmission of Syn (Danzer et al., 2009; Desplats et al., 2009; Hansen et al., 2011) and that aggre gated Syn induces PDlike pathology in recipient cells with damaging consequences (Luk et al., 2009; Waxman and Giasson, 2010; VolpicelliDaley et al., 2011) . More over, they are compatible with histopatho logical studies in humans suggesting that the transmission of misfolded Syn promotes the spreading of pathology in synucleinopa thies such as PD and DLB (Braak et al., 2003; Kordower et al., 2008; Li et al., 2008) , thereby contributing to disease progression. Our data also adds to a growing body of evi dence that the prionlike transmission and propagation of misfolded proteins represents a common process in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis, as well as PD and DLB (Aguzzi and Rajendran, 2009; Brundin et al., 2010; Polymenidou and Cleveland, 2011) .
The efficiency and rapidity with which Syn PFFs induced pathology in M83 mice contrasts with studies of mouse models of other neurodegenerative diseases, most notably Alzheimer's disease pathology, wherein homoge nates of diseased brain tissue, but not synthetic A peptide or recombinant tau protein, efficiently seed plaque and tanglelike pathology after intracerebral or peripheral in jection (MeyerLuehmann et al., 2006; Clavaguera et al., 2009; Eisele et al., 2010) . Although amyloid fibrils repre sent the predominant form of Syn in synthetic prepara tions, the possibility that other Syn species may also transmit pathology and disease cannot be excluded at this point. Nonetheless, the in vivo pathogenic activity of syn thetic Syn PFF preparations required neither templating with diseasederived material nor serial propagation in a cel lular host, indicating that the conformations responsible for transmission were generated in vitro. Although the de novo generation of pathological prions from recombinant protein has also been reported (Barria et al., 2009; Kim et al., 2010; Makarava et al., 2011 ), activity appears to be dependent on tract, suggestive of propagation of Syn pathology along major white matter tracts and that they may serve as sig nificant conduits for disease transmission (Fig. 7, A and B) . Because callosal and commissural fibers also extend bilat erally, they may also represent possible routes for the inter hemispheric transmission of Syn pathology observed at later time points (Fig. 7 B) . In addition, Syn pathology in thalamic and subthalamic areas could also be traced back to the striatal injection site via the internal capsule, a struc ture that fenestrates the dorsal striatum (Fig. 7 A, inset) , further supporting the view that pathological Syn prop agates along neuronal processes.
DISCUSSION
Our data here demonstrate that a single inoculation of patho logical Syn, including Syn PFFs assembled from re combinant protein, is sufficient to induce widespread CNS Syn pathology and accelerate disease in vivo. Impor tantly, the nearidentical pathology initiated by Syn PFFs and diseased brain lysates suggests that Syn PFFs alone can act as a pathogenic agent that ultimately leads to a fatal neurological phenotype in the M83 Tg mouse model. Our findings here compliment recent experimental studies neurons of the substantia nigra and the motor impairments that accompany loss of dopamine function. Although we have demonstrated here that inoculation with either symptom atic M83 mouse brain lysates or Syn PFFs elicited Syn pathology in nigral neurons, our ability to detect motor deficits directly related to dopaminergic dysfunction and other possible neurological symptoms may actually be masked by the most striking feature of our transmission model-the rapidity with which injected animals develop pathology and disease. Nonetheless, our findings clearly suggest a direct relationship between the accumulation of pathological Syn and neurological disease. Indeed, the seemingly irreversible amplification and spread of pathologi cal Syn observed here may explain the relentless neurological decline in patients with pathological synucleinopathies. Finally, these findings may extend to other proteinmisfolding disorders, and thus have implications for developing disease modifying therapies for DLB/PD and other neurodegen erative diseases linked to the accumulation misfolded protein aggregates.
MATERIALS AND METHODS
Animals. M83 mice overexpressing human A53T Syn under the control of the mouse prion protein promoter (Giasson et al., 2002) were maintained on a C57BL/C3H background and Syn / mice (Abeliovich et al., 2000) were maintained on a C57BL/6 background. All housing, breeding, and procedures were performed according to the National In stitutes of Health Guide for the Care and Use of Experimental Animals and approved by the University of Pennsylvania Institutional Animal Care and Use Committee.
Injection material.
Brainstem and spinal cord of aged symptomatic M83 mice were dissected from brains previously stored at 80°C. Tissue was sonicated in sterile PBS (100 mg per 1 ml of buffer) with a handheld probe (QSonica). Homogenates were cleared by centrifugation for 5 min (3,000 g, 4°C) and the resultant supernatant (lysate) was recovered and stored at 80°C until injection. Purification of recombinant Syn proteins and in vitro fibril assembly was performed as previously described (Murray et al., 2003; Luk et al., 2009 ) using human Syn 1120 Myc or WT fulllength human Syn (5 mg/ml). PFFs were collected after 5 d of incubation at 37°C. PFF preparations were diluted into sterile PBS and sonicated briefly before intracerebral injection.
Stereotaxic injections. Male M83 mice (2-4 mo of age) were anesthe tized with an intraperitoneal injection of ketamine hydrochloride (100 mg/kg) and xylazine (10 mg/kg), and stereotaxically injected with either brain lysate (5 µg total protein per brain) or recombinant Syn fibrils (5 µg per brain, unless otherwise indicated). Control M83 animals received either sterile PBS or brain lysate derived from 1moold asymptomatic M83 mice. A single needle insertion (coordinates: +0.2 mm relative to bregma, 2.0 mm from midline) into the right forebrain was used to target the inoc ulum to both the somatosensory cortex and dorsal neostriatum located at a depth of 0.8 and 2.6 mm below the dura, respectively (Fig. S1 E) . Material was injected via a Hamilton syringe at a rate of 0.1 µl per min (2.5 µl total per site) with the needle in place for ≥10 min at each target. Animals were inoculated at both sites unless otherwise indicated. After recovery from surgery, animals were monitored regularly, and sacrificed either upon the onset of paralysis or at various predetermined time points by overdose with ketamine/xylazine and then transcardial perfusion with PBS. For histological studies the brain and spinal cord were removed and underwent overnight postfixation in either neutral buffered formalin the use of brainderived template material or serial passage in cells or animals, suggesting that perhaps additional cofactors are required. Thus, we report the first evidence here that synthetic Syn PFFs alone, including both synthetic WT fulllength human Syn and human Syn 1120 Myc PFFs, can induce DLB/PDlike Syn pathology and transmit a lethal neurodegenerative synucleinopathy in vivo.
Our data also support the idea that pathological Syn can spread over considerable distances to many CNS regions, including cortical, midbrain, and brainstem neurons that are affected in DLB/PD (Braak et al., 2003; Dickson et al., 2009 ). The consistent observation that intracellular Syn inclusions in regions distant from the injection site is accompanied by the presence of Syn pathology within intermediary neuro nal populations is also reminiscent of the hierarchal pattern of progression proposed for human DLB/PD (Braak et al., 2003; Del Tredici and Braak, 2008) . Although propagation of LBs/LNs in human PD is postulated to start in the brain stem and ascend toward neocortical regions with disease pro gression (Braak et al., 2003; Del Tredici and Braak, 2008) , the data presented here and recent studies (VolpicelliDaley et al., 2011) indicate that the transmission of pathological Syn can occur bidirectionally within a network of inter connected populations.
The observation that inoculation into the cortex and stria tum also resulted in robust Syn inclusions in brainstem and cerebellar nuclei, regions that do not share direct innervation with the injection sites, and that the path of transmission of pathological Syn does not appear to be restricted by either the presence or number of intermediary connections, suggests transsynaptic spreading as a possible mode of propagation for pathological Syn species. Although this mechanism has pre viously been proposed for transmission in both prion disease (Scott et al., 1992; Prinz et al., 2003) and CNS viral infection (Callaway, 2008) in neurons, additional studies examining the anatomical relationships between injection sites and affected areas will assist in elucidating the precise pathways involved in Syn spreading. Patients with PD exhibit elevated levels of multimeric Syn in the cerebrospinal fluid which may serve as transmissible seeds for subsequent inclusion formation (Tokuda et al., 2010) . In contrast to our model, however, the primary source of Syn nucleating seeds in PD and DLB remains unknown (Braak et al., 2006) . Despite the established presence of Syn pathology in olfactory and enteric neurons in PD (Wakabayashi et al., 1989; Daniel and Hawkes, 1992; Duda et al., 1999; Beach et al., 2010) , there is currently no di rect evidence that PD or DLB are either infectious or acquired from an external source via nasal or gastrointestinal routes. Rather, the release of pathological Syn species from dying neurons or by exocytosis represents a more probable source of transmissible Syn (Lee et al., 2008; Desplats et al., 2009; Emmanouilidou et al., 2010; Danzer et al., 2011; Hansen et al., 2011) , uptake of which may trigger a reiterative patho genic process like the one described here.
A frequently cited limitation of Tg models of synucleinopathies is the failure to recapitulate pathology in (Thermo Fisher Scientific) or 70% ethanol (in 150 mM NaCl), before being processed and embedded in paraffin. For biochemical studies, tissues were immediately frozen after removal and stored at 80°C until used.
Antibody generation. Rabbits (PRF&L) were immunized with a synthetic peptide corresponding to residues 115-125 of the murine Syn (mSyn) conjugated via an additional Nterminal cysteine residue to keyhole limpet hemocyanin (KLHCDMPVDPGSEAY). The resulting antisera were puri fied using an NHSagarose column conjugated with recombinant fulllength human Syn. Flowthrough fractions were further affinitypurified using agarose conjugated to recombinant mSyn. Polyclonal antibodies specific to Syn phosphorylated at serine 129 (pSer129) was generated by injecting rabbits with the KLHconjugated peptide CAYEMPSEEGYQ (phosphory lated residue underlined). Phosphospecific antibodies were enriched by sequentially incubating antisera with NHSagarose conjugated to recombi nant Syn and the phosphopeptide.
Immunohistochemistry and mapping of -Syn pathology. Immuno histochemistry was performed on 6µmthick serial sections as previously de scribed (Duda et al., 2000) . Primary antibodies used and working dilutions are detailed in Table S1 . For histological and cell mapping studies, coronal sections were stained using 3diaminobenzidine (Vector Laboratories) as a chromo gen. Immunoreactive inclusions/cells and neurites were mapped at multiple rostrocaudal levels corresponding to 1.3, 0.26, 1.75, 3.0, 4.3, and 6.0 mm relative to Bregma. For doublelabeling studies, immunoreactivity was revealed using the appropriate fluorescent secondary antibodies conju gated to Alexa Fluor 488 or 594 (Invitrogen). Images were captured using a DP71 digital camera connected to a BX51 microscope (Olympus). Collages were assembled using Photoshop CS2 software (Adobe).
Biochemical analysis. Brain regions of interest were dissected, weighed, and sequentially extracted using high salt (HS) buffer (50 mM Tris, pH 7.5, 750 mM NaCl, and 5 mM EDTA), HS buffer containing 1% TritonX100, RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% NP40, 0.5% sodium deoxycholate, and 0.1% SDS), 1% SDS buffer (50 mM Tris, pH 7.5, and 1% SDS), and 66% formic acid. Protease and phosphatase inhibitors (Roche) were added to buffers before use. For each extraction step, samples were sonicated and sedimented at 100,000 g for 30 min. 3 ml of buffer was used per gram of tissue in each extraction step. Protein concen trations were determined using the BCA assay (Thermo Fisher Scientific), and samples (20 µg total protein) were separated on SDSpolyacrylamide gels (4-20% gradient) and transferred onto nitrocellulose membranes for probing with various primary antibodies (Table S1 ). Target antigens were detected using an Odyssey FC scanner (LiCor) after incubation with the appropriate infrared secondary antibodies.
Online supplemental material. Fig. S1 summarizes the Syn pathology observed in major CNS areas of M83 mice after inoculation with patho logical Syn or control inoculum. Table S1 is a list of antibodies used in this study. Online supplemental material is available at http://www.jem .org/cgi/content/full/jem.20112457/DC1.
